High Demand for At-Home COVID Tests Could Hamper Supply, Abbott Says

MONDAY, Aug. 30, 2021 (HealthDay Information)

Demand from customers for Abbott Laboratories’ at-residence COVID-19 exams has attained “unparalleled” concentrations and offer may perhaps be confined in the coming months, the organization suggests.

Gross sales have skyrocketed due to the surge in scenarios driven by the remarkably transmissible Delta variant, CNN noted.

“We’re observing unprecedented demand as case fees increase — and we have been scaling up production considering the fact that Delta turned the dominant strain and new CDC guidance referred to as for a reprioritization of testing,” Abbott spokesperson John Koval told CNN.

“Today, there are tens of thousands and thousands of BinaxNOW exams in different configurations and supply chains. We are doing the job with our consumers to guarantee tests get to the place they are most needed and we are ramping again up, as we did past calendar year,” Koval explained. “There will be some provide constraints over the coming weeks as amplified potential arrives on the internet.”

Two other COVID-19 examination developers — Labcorp and Quest Diagnostics — also told CNN they are looking at elevated demand.

“We proceed to see improves in demand for COVID-19 PCR tests thanks to Delta and as the school yr starts,” Christopher Allman-Bradshaw, a spokesperson for Labcorp, instructed CNN. “We report figures on a quarterly foundation that we have noticed an maximize in screening as caseloads rise.”

Quest Diagnostics has seen a identical rise in demand from customers for diagnostic tests.

“Whilst COVID-19 molecular diagnostic testing demand from customers and positivity rates have climbed in modern months because of to the nationwide boost in COVID-19 cases, we are executing and reporting the majority of COVID-19 exams within just 1 working day,” Kim Gorode, a spokesperson for Quest Diagnostics, explained to CNN. “We have ample capacity, but are introducing molecular examination devices to bolster readiness in pick out laboratories in the Southeast and Southwest, in which demand from customers is comparatively substantial.”

Extra information

Check out the U.S. Centers for Sickness Control and Prevention for a lot more on COVID-19 screening.

Supply: CNN

Robert Preidt

MedicalNews
&#13
Copyright © 2021 HealthDay. All rights reserved.